Chronological changes of α-adrenoceptor-mediated vascular constriction in Otsuka-Long-Evans-Tokushima fatty rats

Hypertension Research

Volumn 26, Issue 7, 2003, Pages 559-567

  Yoshida, Yasumasa ^a   Ohyanagi, Mitsumasa ^a   Iwasaki, Tadaaki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

adrenoceptor; Insulin resistance; Peripheral arterior vasoconstriction

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; BRIMONIDINE; N(G) METHYLARGININE; PHENYLEPHRINE;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM LESION; HYPERTENSION; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; RAT; RAT STRAIN; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; DIABETES MELLITUS, TYPE 2; HYPERTENSION; INSULIN RESISTANCE; RATS; RATS, INBRED OLETF; RECEPTORS, ADRENERGIC, ALPHA; TIME FACTORS; VASOCONSTRICTION;

EID: 0042062342     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.559     Document Type: Article

References (28)

1. Modan M, Halkin H, Almog S, et al: Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75: 809-817.
2. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993; 11: 309-317.
3. Salomaa VV, Strandberg TE, Vanhanen H, et al: Glucose tolerance and blood pressure: long term follow up in middle aged men. BMJ 1991; 302; 493-496.
4. Ferrannini E, Buzzigoli G, Bonadonna R, et al: Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
5. Gress TW, Nieto FJ, Shahar E, et al: Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus: Atherosclerosis Risk in Communities Study. N Engl J Med 2000; 342: 905-912.
6. Tuck ML: Obesity, the sympathetic nervous system, and essential hypertension. Hypertension 1992; 19(Suppl 1): 167-177.
7. Ping P, Faber JE: Characterization of alpha-adrenoceptor gene expression in arterial and venous smooth muscle. Am J Physiol 1993; 265: H1501-H1509.
8. Haywood GA, Gullestad L, Katsuya T, et al: AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation 1997; 95: 1201-1206.
9. Feldman RD, Bierbrier GS: Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet 1993; 342: 707-709.
10. Baron AD: Insulin resistance and vascular function. J Diabet Complications 2002; 16: 92-102.
11. 2+-regulation of insulin sensitivity. J Nutr 1995; 125: 1738S-1743S.
12. He Y, MacLeod KM: Modulation of noradrenaline-induced vasoconstriction in isolated perfused mesenteric arterial beds from obese Zucker rats in the presence and absence of insulin. Can J Physiol Pharmacol 2002; 80: 171-179.
13. Hsueh WA, Anderson PW: Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus. Hypertension 1992; 20: 253-263.
14. Tesfamariam B, Brown ML, Cohen RA: Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 1991; 87: 1643-1648.
15. Arcaro G, Cretti A, Balzano S, et al: Insulin causes endothelial dysfunction in humans. Circulation 2002; 105: 576-582.
16. Kawano K, Hirashima T, Mori S, et al: Spontaneous long-term hyperglycemic rat with diabetic complications, Otsuka Long-Evans-Tokushima Fatty (OLETF) strains. Diabetes 1992; 41: 1422-1428.
17. Ishida K, Mizuno A, Min Z, et al: Which is the primary etiologic event in Otsuka Long-Evans-Tokushima Fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus, insulin resistance, or impaired insulin secretion? Metabolism 1995; 44: 940-945.
18. Taylor PD, Graves JE, Poston L: Selective impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated resistance arteries of the streptozotocin-induced diabetic rat. Clin Sci (Colch) 1995; 88: 519-524.
19. 2+ handling in the aorta of Zucker obese rats with insulin resistance. Diabetes 1996; 45 (Suppl): S55-S58.
20. Wakabayashi I, Hatake K, Kimura N, et al: Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sci 1987; 40: 643-648.
21. Bohlen HG, Lash JM: Endothelial-dependent vasodilation is preserved in non-insulin-dependent Zucker fatty diabetic rats. Am J Physiol 1995; 268: H2366-H2374.
22. Sakamoto S, Minami K, Niwa Y, et al: Effect of exercise training and food restriction on endothelium-dependent relaxation in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous NIDDM. Diabetes 1998; 47: 82-86.
23. Takagawa Y, Berger ME, Tuck ML, et al: Impaired endothelial alpha-2 adrenergic receptor-mediated vascular relaxation in the fructose-fed rat. Hypertens Res 2002; 25: 197-202.
24. Irving RJ, Walker BR, Noon JP, et al: Microvascular correlates of blood pressure, plasma glucose, and insulin resistance in health. Cardiovasc Res 2002; 53: 271-276.
25. Kosegawa I, Katayama S, Kikuchi C, et al: Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance. Hypertens Res 1996; 19: 37-41.
26. Faber JE, Yang N, Xin X: Expression of α-adrenoceptor subtypes by smooth muscle cells and adventitial fibroblast in rat aorta and in cell culture. J Pharmacol Exp Ther 2001; 298: 441-452.
27. Han C, Li J, Minneman KP: Subtypes of α1-adrenoceptors in rat blood vessels. Eur J Pharmacol 1990; 190: 97-104.
28. Tuda K, Tuda S, Masuyama Y, Goldstein M: Norepinephrine release and neuropeptide Y in medulla oblongata of spontaneously hypertensive rats. Hypertension 1990; 15: 784-790.